ASP Isotopes, Inc. (ASPI)
5.50
-0.13
(-2.31%)
USD |
NASDAQ |
Jul 06, 13:14
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 692.47M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -19.91% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 19.21 |
| Price to Book Value | 2.396 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.906 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX. |
| URL | http://www.aspisotopes.com |
| Investor Relations URL | https://ir.aspisotopes.com/ |
| HQ State/Province | Texas |
| Sector | Materials |
| Industry | Chemicals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Aug. 14, 2026 (est.) |
| Last Earnings Release | May. 22, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX. |
| URL | http://www.aspisotopes.com |
| Investor Relations URL | https://ir.aspisotopes.com/ |
| HQ State/Province | Texas |
| Sector | Materials |
| Industry | Chemicals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Aug. 14, 2026 (est.) |
| Last Earnings Release | May. 22, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |